(T 15) Real-World Impact of Eptinezumab Treatment on Migraine-Related Cognitive Symptoms in Participants in Whom ≥1 Prior CGRP-Targeted Therapy had Failed: 12-Month Results of a Prospective Study

Presenting Author(s)

Amaal J. J. Starling, MD

Associate Professor of Neurology
Mayo Clinic Arizona
Scottsdale, Arizona, United States

Richard B. Lipton, MD

Edwin S. Lowe Professor and Vice Chair of Neurology; Director, Montefiore Headache Center
Montefiore Medical Center and the Albert Einstein College of Medicine
Bronx, NY, United States
SS

Seema Soni-Brahmbhatt, PharmD

Lundbeck LLC
Deerfield, Illinois, United States
SR

Stephane A. Regnier, PhD

Lundbeck LLC
Deerfield, Illinois, United States
SA

Susanne F. F. Awad, PhD

H. Lundbeck A/S
Copenhagen, Hovedstaden, United States
SG

S. Wald Grossman, MS

Lundbeck LLC
Deerfield, Illinois, United States
MT

Michelle Townshend, MSN, RN

ZS Associates, United States
EE

Emad Estemalik, MD

Section Head - Headache Medicine
Cleveland Clinic Lerner College of Medicine
Cleveland, Ohio, United States